Specialist Needle and Syringe Programme – Understanding change in specialist needle and syringe programme
Authors: Communicable Disease Inclusion Health Programme, Substance Misuse Team, Health Protection Division, Public Health Wales
Published on: 27th July 2026
Needle and syringe programmes (NSP) provide comprehensive harm reduction interventions for the population of people who use drugs. NSP provision is a vital tool in minimising the transmission of blood-borne viruses and bacterial infections through providing access to sterile injecting equipment. NSP also provide harm reduction advice on overdose prevention, take-home naloxone, and pathways into wider health and social care.
Data from the Harm Reduction Database (HRD) has shown a significant decline in NSP activity across Wales over several years and this prompted a comprehensive review of contextual and social factors influencing NSP activity. This report is one of three and focuses on NSP provision from specialist sites provided by statutory organisations and third-sector services. The other two reports present peer perspectives of the factors contributing to the decline in NSP activity and examine the social and contextual factors influencing NSP activity in community pharmacies.
This review covers 95% of specialist NSP sites across Wales and 104 staff members were interviewed. The following 4 key themes were identified:
- Barriers and facilitators impacting utilisation of specialist NSP services
- Social and contextual factors impacting activity at specialist NSP services
- Increasing health and social care need: Implications for specialist NSP service delivery
- Workforce training needs to strengthen NSP service delivery
Each theme will be discussed in turn.
Report downloads
Specialist Needle and Syringe Programme - Understanding change in specialist needle and syringe programme
PDF, 583KB
Download PDF - Specialist Needle and Syringe Programme - Understanding change in specialist needle and syringe programme (583 KB)
Download PDFRelated reports
-
Harm reduction database Wales: Drug related mortality (Annual report 2025)
Executive summary Key findings and trends Take-home Naloxone (THN) – HRD Drug deaths in Wales – ONS Fatal / non-fatal drug poisoning reviews – HRD
Published on:
-
Data mining Wales: The annual profile for substance misuse 2024 to 2025
Executive summary Population level trends Children and young people (under 25 years) Adults aged 25-49 years Older adults, aged 50 years and above
Published on:
-
Needle and Syringe Programme Community Pharmacy – Understanding change in needle and syringe programme transactions within a community pharmacy setting
The investigation has found that the factors impacting on the number of transactions recorded on the Harm Reduction Database (HRD) are multifactorial and vary both within and across the health […]
Published on: 10th January 2024
-
Needle and Syringe Programme Activity in Wales Annual Report 2025 to 2026
This report for 2025-26 evidences the sustained and substantial reduction in the activity of people who use drugs (PWID) accessing needle and syringe programmes (NSP) across Wales since 2020. This […]
Published on: 27th July 2026
-
Public Health Wales Research & Evaluation Highlights Report 2025 to 2026
Public Health Wales leads and supports research to improve health, reduce inequalities and strengthen public health services in Wales.
Published on:
-
Secondary school children’s health and well-being dashboard
Next update: To be announced Contact for queries or feedback Introduction This is a collaborative piece of work between The School Health Research Network (SHRN) and Public Health Wales. This […]
Published on: 27th November 2025
Related data
-
Primary school children’s health and well-being dashboard data
Last reviewed: 18th June 2026
-
Secondary school children’s health and well-being dashboard data
Last reviewed: 27th November 2025